Easy-on Easy-off: Is the Promise of Intravenous P2Y12 Inhibition Realized in AMI Cardiogenic Shock?

J Card Fail. 2024 Oct;30(10):1241-1243. doi: 10.1016/j.cardfail.2024.08.036.

Authors

Megha Prasad¹, Srihari S Naidu²

Affiliations

¹ Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY.
² Department of Cardiology, Westchester Medical Center, Valhalla, NY. Electronic address: [email protected].

PMID: 39389733
DOI: 10.1016/j.cardfail.2024.08.036

No abstract available

Keywords: Cardiogenic shock; cangrelor; intravenous P2Y12 inhibitor; thrombus.

Publication types

Editorial

MeSH terms

Administration, Intravenous
Humans
Myocardial Infarction / drug therapy
Purinergic P2Y Receptor Antagonists* / administration & dosage
Purinergic P2Y Receptor Antagonists* / therapeutic use
Shock, Cardiogenic* / therapy

Substances

Purinergic P2Y Receptor Antagonists